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Abstract
Purpose Preoperative nutrition is beneficial for malnourished
cancer patients. Yet, there is little evidence whether or not it
should be given to nonmalnourished patients. The aim of this
study was to assess the need to introduce preoperative nutri-
tional support in patients without malnutrition at qualification
for surgery.
Methods This was a prospective, two-arm, randomized, con-
trolled, open-label study. Patients in interventional group re-
ceived nutritional supplementation for 14 days before surgery,
while control group kept on to their everyday diet. Each
patient’s nutritional status was assessed twice—at qualifica-
tion (weight loss in 6 months, laboratory parameters: albumin,
total protein, transferrin, and total lymphocyte count) and
1 day before surgery (change in body weight and laboratory
parameters). After surgery, all patients were followed up for
30 days for postoperative complications.
Results Fifty-four patients in interventional and 48 in control
group were analyzed. In postoperative period, patients in
control group suffered from significantly higher (p<0.001)
number of serious complications compared with patients re-
ceiving nutritional supplementation. Moreover, levels of all
laboratory parameters declined significantly (p<0.001) in the-
se patients, while in interventional arm were stable (albumin
and total protein) or raised (transferrin and total lymphocyte
count).
Conclusions Preoperative nutritional support should be intro-
duced for nonmalnourished patients as it helps to maintain
proper nutritional status and reduce number and severity of
postoperative complications compared with patients without
such support.
Keywords Cancer-relatedmalnutrition . Preoperative
nutrition . Nutritional supplementation . Cancer surgery
Abbreviations
ESPEN European Society for Clinical Nutrition and
Metabolism
TLC Total lymphocyte count
ERAS Enhanced recovery after surgery
CTCAE Common Terminology Criteria for Adverse Events
Introduction
Gastrointestinal cancer patients are at high risk for disease-
related malnutrition and cachexia. This is a result of many
coexisting factors including aggressive and catabolic biology
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of the disease, food intake and intestinal passage disturbances,
and stress-related anorexia [1]. Therefore, metabolic deterio-
ration of these patients starts long before its clinical effects can
be seen.
As far as malnourished gastrointestinal cancer patients are
concerned, numerous randomized trials and guidelines on
preoperative nutrition were published [2–8]. All of these agree
that preoperative nutrition is beneficial and necessary for these
patients, as it improves their metabolic status and results in
better postoperative outcomes, especially in means of compli-
cations. According to European Society for Clinical Nutrition
andMetabolism (ESPEN) guidelines, supplementation should
be given for 10–14 days preoperatively, even if surgery must
be delayed [3–5]. At the same time, there is very little evi-
dence on preoperative nutrition of nonmalnourished cancer
patients. Most of currently available information comes from
single randomized controlled trials (RCTs), or as secondary
results of malnutrition trials, with incoherent results [6, 9]. The
question, whether or not preoperative nutrition should be
introduced in these patients is very important, as this group
is highly represented, especially among less aggressive neo-
plasms, e.g., colorectal cancer. Even though these patients do
not meet the criteria for malnutrition (albumin level, <35 g/l;
weight loss, >10%; bodymass index (BMI), <18.5) [10], their
metabolic status is often already affected by the disease-
related catabolism, which if uncontrolled, can lead to
malnutrition.
To answer this question, we set up a trial to determine
whether preoperative nutritional support should be routinely
used in gastrointestinal cancer patients with no signs of mal-
nutrition, and if such approach will have positive clinical
effects.
Materials and methods
The study was a prospective single-center, two-arm, random-
ized, controlled, open-label trial. All patients qualified by the
study team for elective, radical gastrointestinal, and abdomi-
nal cancer surgery in the Department of Surgical Oncology of
Medical University of Gdansk, Poland between May 2011
and April 2013 were screened for eligibility. Screening was
based on patients’ medical data and clinical and radiological
findings.
To enter the study, patients had to meet all inclusion
criteria. All patients were adults in good general condition
(>70 in Karnofsky scale) [11] with either primary or second-
ary gastrointestinal and abdominal cavity malignancy, not
meeting criteria for malnutrition (albumin level, <35 g/l;
weight loss, >10 %) at screening. The tumor had to be resect-
able based on preoperative radiological and clinical examina-
tions at the moment of qualification for surgery. Patients with
other major gastrointestinal diseases or signs of mechanical
ileus were not eligible to participate. Also, other serious
medical conditions, which may affect nutritional status, as
well as renal and liver failure excluded from the study.
Eligible patients were randomized to one of two parallel
study groups—interventional or control. Randomization was
based on a computer-generated simple randomization table
prepared by an independent statistician. No blocking or strat-
ification was used. Patients in interventional arm were given
on-market oral nutritional supplements (Nutridrink Protein ®,
N. V. Nutricia) in addition to their normal diet. They were
asked to drink two 200-ml bottles of this hypercaloric formula
(1.5 kcal/ml) daily for 14 days before surgery. Each bottle
contained 20 g of protein. Patients in the control group were
asked to keep on to their normal eating habits. No supplemen-
tations or changes in composition of their diet were made.
All patients were checked for signs of malnutrition twice.
First assessment was performed at qualification for the study
and second, after hospital admission, 1 day before the surgery.
The awaiting period for surgery was longer than intervention
time (median 19 days in interventional and 18 in control
group, with no statistical significance); therefore, patients
were asked to start drinking nutritional supplements exactly
14 days prior to scheduled hospital admission. Initial screen-
ing comprised patients’ age and general performance
(Karnofsky scale), current weight, BMI, and weight loss with-
in 6 months before qualification for surgery. Blood samples
for laboratory tests—albumin, total protein, transferrin level,
and total lymphocyte count (TLC) were obtained. Weight loss
assessment was based on patients’ information on body
weight 6 months earlier and weight check at qualification for
the study. At hospital admission, patients were checked for
change in the body weight, BMI, and blood parameters’
values since qualification for the study. Perioperative manage-
ment of all patients was performed according to Enhanced
Recovery After Surgery (ERAS) protocols. After surgery,
depending on type of procedure performed, patients were
given immediate nutritional intervention. Patients after oe-
sophageal and gastric resections received enteral nutrition
for 4–5 days followed by introduction of oral feeding. Rest
of the patients was treated with oral nutrition supplemented by
ONS, if necessary starting from first day after surgery.
After surgery all patients were followed-up for postoperative
complications for 30 days. Complications’ occurrence and their
severity according to Common Terminology for Criteria for
Adverse Events (CTCAE) classification were noted [12]. This
is a five-grade classification, where: grade 1 stands for mild
complication requiring no intervention, grade 2—moderate,
when minor intervention is indicated. Grade 3 complications
require intervention including pharmacological, surgical, and
hospital admission if necessary, grade 4 are life-threatening
complications requiring intensive treatment including immedi-
ate surgery and grade 5 stands for death. For the purpose of this
study, severity and types of postoperative complications were
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grouped. Complications in grades 1–2 were treated as mild, and
3–5 as severe. We also divided them in three main types—
infectious, surgical, and general.
Local ethics committee approval was obtained and all
patients signed informed consent. The study protocol was
registered in clinicaltrials.gov database, study ID:
NCT01894828
Statistics
All data were gathered and analyzed on Per Protocol basis
using IBM SPSS 20.0 software. Normality was assessed using
the Kolmogorov-Smirnov test. Statistical analyses of data
within patient groups were performed using the Wilcoxon
signed ranks test. Mann-Whitney U test was used to compare
change in values between the groups. Fisher’s exact test was
used to compare discrete variables. p≤0.05 was considered to
be statistically significant. Data are presented as median value
with first (Q1) and third quartile (Q3) or number of patients.
Complications incidence and severity were analyzed be-
tween the groups. We assumed an overall complication rate
for 30 % in patients not receiving nutritional supplementation.
Reduction to the level of 15 % was considered proving effi-
cacy of nutritional supplementation.
Sample size was calculated at CI=95 % and 80 % power for
200 patients in each arm. During the study, based on clinical
observations of both groups, we noticed higher occurrence of
complications in control group, therefore we decided to perform
an interim analysis. It revealed significantly higher number of
serious postoperative complications in control group compared
with those receiving supplementation. There were also labora-
tory signs of metabolic deterioration of these patients.
Results
FromMay 2011 to April 2013, 113 patients entered the study.
Four patients were preoperatively disqualified from surgical
treatment after entering the study, and two patients did not
show up for hospital admission. The four disqualified patients
were of borderline resectability, later considered unresectable
after preoperative reevaluation of diagnostic images at a ref-
erence radiology department. Five patients had incomplete
data. They were not included in the final analysis, because it
was impossible to calculate changes in laboratory parameters’
and body weight values without all results. One hundred two
patients with complete data were analyzed—54 in interven-
tional and 48 in control group. Interventional group comprised
of 24 male and 30 female patients; 28 men and 20 women
were included in control group. Detailed information on dis-
ease characteristics are gathered in Table 1.
Baseline values of anthropometric parameters at qualifica-
tion for the study were comparable between the groups
(Table 2). However median age and body weight were higher
in control group (67 vs 60 years and 74 vs 68 kg, respective-
ly), while median percent weight loss was higher in interven-
tional group (7.4 vs 6.3 %). These differences were not sig-
nificant. Also, laboratory parameters values were similar in
both groups, with no significant differences. At this moment,
patients in both groups did not meet criteria for malnutrition.
What is more, high BMI values (24.2 vs 26.1) were at bor-
derline for overweight. Yet, it is worth noticing that 6-month
weight loss around 7 % and albumin level in lower reference
values may indicate already existing disease-related catabo-
lism in both study groups.
On second assessment, changes in laboratory parameters and
body weight values were measured. Significant differences
(p<0.001) between study groups were observed regarding all
laboratory parameters’ values and body weight. Values of all
measured parameters decreased significantly (p<0.001) in con-
trol group, with albumin and weight loss values at borderline
level for malnutrition, whereas in supplementation group their
levels increased. Significant changes were observed in median
body weight (p<0.001), transferrin (p=0.032), and TLC (p=
0.05) values. Albumin and total protein levels changed slightly,
with no statistical significance (Table 2).
Postoperative complications
Number and severity of postoperative complications differed
between study groups (Tables 3 and 4). Total number of com-
plications was significantly higher in control group (17 vs 8; p=
0.04). These differences were also visible when divided into
subgroups, by their severity—mild (6 vs 3; p=0.036) and severe
(11 vs 5; p<0.001). The assumed reduction of total complica-
tions’ percentage in patients receiving nutritional supplementa-
tion compared with control group was achieved (from 35.4 to
14.8 %). Patients in control group suffered from higher number
of infectious complications, mainly wound infections. However,
pneumonia and sepsis, one case of each, were observed only in
patients receiving supplementation. Although surgical compli-
cations occurred in both groups comparably, those, which are
strictly connected with nutritional status—anastomotic leakage
and evisceration, were observed only in patients without sup-
plementation. Severe general complications, including one fatal,
being a result of mixed cardiac-neurologic incident, were also
observed only in control group.
Discussion
Preoperative nutrition plays an important role in preoperative
management of surgical patients. It helps to restore proper
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nutritional status, which results in reduced number of postop-
erative complications. According to international guidelines,
it should be given for 10–14 days before surgery. However,
these guidelines generally apply to malnourished patients,
which require intensive nutritional support with specialized
diets, often in hospital setting.
According to the ESPEN guidelines, weight loss >10 %
in 6 months is a risk factor for postoperative complications,
and is borderline value for malnutrition. Even though this
factor has been broadly studied, literature data on what
level should be treated as threatening are inconsistent.
Makela et al. in a case control study on a group of 44
left-sided colon cancer patients found statistically higher
incidence of anastomotic leakage in subjects with weight
loss>5 %, which was also proven by Gregg to be a
negative predicting factor for early postoperative death in
patients with bladder cancer [13, 14]. On the other hand,
Antoun et al. found higher incidence of severe postopera-
tive complications in patients with over 15 % weight loss
[15]. Patients in our study at screening suffered from me-
dian weight loss at the level of 6–7 %, which already had a
negative impact on postoperative outcome. Having in mind
that cancer-related weight loss and deterioration is a long-
term and gradual process, basing on the results of our and
other studies we think, that oral supplementation should be
given to any cancer patient who suffered weight loss before
surgery. It is also of utmost importance to screen each of these
patients for malnutrition and nutritional risk, not relying only
on weight loss values. The available screening tools can
provide us additional and necessary information on signs
and symptoms of the disease, which helps to make decision
on what approach would be best for the patient.








Sigmoid colon 5 9
Ascending colon 5 4
Ovaries 5 0
Secondary abdominal tumor 4 2
Descending colon 3 2
Esophagus 3 2
Primary abdominal tumor 3 1
Peritoneal pseudomyxoma 1 1
Anus 1 1
Pancreas 1 0
Transverse colon 1 0
Appendix 1 0
Liver 0 1
Small intestine 0 1
Table 2 Values of demographic
and laboratory parameters of pa-
tients at qualification for surgery
and in second assessment, after
the intervention/control (median
values)
Interventional arm (N=54) Control arm (N=48)
Median Q1 Q3 p value Median Q1 Q3 p value
Demographic (baseline values)
Age 60 49 68 67 61 73
Height (m) 1.68 1.63 1.75 1.68 1.64 1.75
Body weight (kg) 68 58 82 74 63 86
BMI (kg/m2) 24.2 21.2 28.7 26.1 22.5 28.4
Weight loss in 6 months (kg) −5 −10 −1 −5 −8 −1
% weight loss in 6 months 7.4 9.5 0.6 6.3 9.6 1.8
Karnofsky score 80 80 90 80 80 90
Nutritional (baseline values)
Albumin (g/l) 38 36 41 38 36 42
Total protein (g/l) 70 67 74 71 67 75
Transferrin (g/l) 2.44 2.20 2.84 2.50 2.16 2.89
Total lymphocyte count (G/l) 1.53 1.13 2.08 1.76 1.23 2.08
Nutritional (after intervention/control)
Body weight (kg) 70 59 84 <0.001 73 61 86 <0.001
Albumin (g/l) 39 35 43 0.849 34 31 41 <0.001
Total protein (g/l) 72 66 78 0.075 67 59 75 <0.001
Transferrin (g/l) 2.51 2.24 3.04 0.032 2.19 1.66 2.86 <0.001
Total lymphocyte count (G/l) 1.65 1.03 2.38 0.05 1.38 0.7 1.98 <0.001
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In literature, there is little evidence on what approach
should be taken towards patients without malnutrition, and
the data available are inconclusive. There have been several
studies performed on this group of surgical patients, but the
differences in their methodology and equivocal results render
comparisons very difficult [16, 17]. Most of these trials com-
pared enteral and parenteral nutrition, with control groups not
receiving any support. The nutrition period was 5–7 days, and
all of the authors used immuno-enhanced formulas. Even
though, the clinical effect of these studies, seen in reduced
number of complications was similar to ours, it is hard to
compare them with our study. Not only did we use oral
formulas without immuno-enhancement but also time of the
intervention was longer. To our best knowledge, there has
been only one study, which concentrated on preoperative oral
nutritional supplementation, however again with immuno-
enhancement [18]. Giger-Pabst et al. in a RCT- administered
oral formulas for 3 days preoperatively, but with no differ-
ences in clinical outcome between the groups. In our opinion,
this was caused by relatively short time of treatment, which
despite stimulation of the immune system, was not sufficient
to exert expected biological response. Prolonging the inter-
vention time in our study enabled reduction of postoperative
complications and stopped patients’ catabolic deterioration,
seen in stable levels of laboratory parameters. The 14-day
period of supplementation seems to be the shortest necessary
to achieve such effect. It is possible to prolong this period with
oral nutritional supplementation, because unlike enteral or
parenteral formulas, it does not require hospital setting and
can be used at home in the awaiting presurgical period.
Oral nutritional supplements are generally very well toler-
ated, which results in high compliance. Their consistency,
together with high-energy load and small volume needed to
provide sufficient amount of nutritional components enable
proper nutrition even for patients with dysphagia or intestinal
passage disturbances. Therefore, they are commonly used in
oncological and geriatric patients who experience this type of
difficulties. Although many studies regarding compliance to
ONS have been published so far, to our best knowledge only
one systematic review has been made to summarize those
studies [19]. Hubbard et al. reviewed 46 studies of all types
with 4,328 patients in which compliance to ONS was mea-
sured. Those studies compared patients with various diseases
(oncological, geriatric, respiratory, renal, and fractures) receiv-
ing supplementation in ambulatory as well as inpatient setting.
The overall compliance to prescribed ONS was 78 % with
most of studies (62 %) at the level of >75 %. This high
compliance was seen regardless of patient type, disease char-
acteristics or healthcare setting. Even though in our study
compliance to ONS was not calculated separately, it has been
checked based on verbal response of our patients. We did not
notice any significant noncompliance to the prescribed ONS,
which corresponds with the results of cited studies.
Few authors questioned superiority of immunomodulating
formulas in preoperative nutrition compared with formulas not
containing these agents. In numerous studies, it has been shown
that there were no differences in overall mortality, morbidity,
and cost-effectiveness between these approaches [8, 20]. Some
of them pointed out that timing of the nutrition ismore important
factor than its type. Klek et al. in a randomized trial comparing
different approaches towards perioperative nutrition showed that
regardless of nutrition content, preoperative administration is of
utmost importance to prevent postoperative complications. [21]
Even though in our study the supplements used were without
immunostimulating agents, the biological effect achieved was
similar to those, which used enteral immunoenriched formulas.
The number of infectious complications, mainly surgical site
infections, was reduced, which was a result of positive impact
exerted on immunological system by the supplements. Yet,
these complications, although most frequent, are not life











Mechanical ileus 1 1
Gastric bleeding 1 0
Esophageal graft perforation 1 0
Anastomotic leakage 0 2
Evisceration 0 2
Other general
Fluid-electrolyte disturbances 0 1
Heart attack 0 1
Death 0 1
Total 8 17







Grade 1 (mild) 2 5 0.036
Grade 2 (moderate) 1 1
Grade 3 (severe) 4 6 <0.001
Grade 4 (life threatening) 1 4
Grade 5 (death) 0 1
Total 8 17
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threatening, and less significant from clinical point of view.With
nutritional supplementation, we managed to reduce number of
strictly surgical complications connected directly with one’s
nutritional status, such as anastomotic leakage or evisceration.
Higher incidence of severe complications, observed in
course of the study was the reason for performing a, previous-
ly not-planned interim analysis. Even though the number of
patients included did not reach the calculated one, its results
were sufficient to draw conclusions. Therefore, we decided to
terminate the study prematurely.
Conclusions
Preoperative nutritional support is beneficial and should be
routinely used in abdominal and gastrointestinal cancer pa-
tients with no clinical signs of malnutrition. Such approach
reduces the number and severity of postoperative complica-
tions, especially of anastomotic dehiscence and leakage. Oral
nutritional supplementation with no immunomodulation giv-
en for 14 days divides the total number of postoperative
complications in patients with gastrointestinal cancers.
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